The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
May. 15, 2018
Filed:
Oct. 13, 2016
Applicant:
Oklahoma Medical Research Foundation, Oklahoma City, OK (US);
Inventors:
Rheal A. Towner, Piedmont, OK (US);
Robert A. Floyd, Oklahoma City, OK (US);
Assignee:
OKLAHOMA MEDICAL RESEARCH FOUNDATION, Oklahoma City, OK (US);
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/15 (2006.01); A61K 31/185 (2006.01); A61K 45/06 (2006.01); A61K 31/166 (2006.01); A61K 31/175 (2006.01); A61K 31/4748 (2006.01); A23L 33/10 (2016.01); A61N 5/10 (2006.01);
U.S. Cl.
CPC ...
A61K 31/15 (2013.01); A23L 33/10 (2016.08); A61K 31/166 (2013.01); A61K 31/175 (2013.01); A61K 31/185 (2013.01); A61K 31/4748 (2013.01); A61K 45/06 (2013.01); A61N 5/10 (2013.01);
Abstract
The present invention involves the use of 2,4-disulfonyl phenyl tert-butyl nitrone (2,4-ds-PBN) in the treatment and prevention of gliomas. The 2,4-ds-PBN may be used alone or combined with other traditional chemo- and radiotherapies and surgery, to treat or prevent glioma occurrence, recurrence, spread, growth, metastasis, or vascularization.